|
|
|||||||||
Basic Science Investigation |
1 Division of Nuclear Medicine, University Hospital Gasthuisberg and Katholieke Universiteit Leuven, Leuven, Belgium; 2 Bio-Imaging Laboratory, University of Antwerp, Antwerp, Belgium; 3 Laboratory for Neurobiology and Gene Therapy, Molecular Medicine, Katholieke Universiteit Leuven, Leuven, Belgium; and 4 Laboratory of Radiopharmaceutical Chemistry, Katholieke Universiteit Leuven, Leuven, Belgium
Correspondence: For correspondence or reprints contact: Cindy Casteels, MSc, Division of Nuclear Medicine, University Hospital Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. E-mail: cindy.casteels{at}uz.kuleuven.ac.be
| ABSTRACT |
|---|
|
|
|---|
0.0004) and a striatal decrease in DAT availability (P
0.0005, corrected). Conclusion: MRI-based small-animal PET templates facilitate accurate assessment and spatial localization of rat brain function using VOI or voxel-based analysis. Regional intersubject and testretest variations found in this study, as well as registration errors, indicate that accuracy comparable to the human situation can be achieved. Therefore, small-animal PET with advanced image processing is likely to play a useful role in detailed in vivo molecular imaging of the rat brain.
Key Words: Paxinos atlas SPM VOI analysis microPET spatial normalization
| INTRODUCTION |
|---|
|
|
|---|
An important step in functional neuroimaging analysis is the development of methods to combine data from different subjects into a common atlas space (3). Spatial normalization, using operator-independent voxel-based algorithms, can increase the sensitivity of low-magnitude responses and facilitate group comparisons (4). The group comparisons can be performed using either automated voxel-based or operator-independent volume-of-interest (VOI) analysis on probabilistic atlases that are oriented into a common stereotactic spacefor example, according to Talairach and Tournoux for humans (5). For small-animal imaging, a common digital atlas or template to enable spatial normalization of animal brain MR images has been developed for rats (6), baboons (7,8), and macaque brain. Other atlas-based image analysis methods have been developed as wellfor example, by means of simulated PET targets (9), derived from a digitized cryosectioned atlas of a single rat and used in combination with predefined VOIs for quantification of small-animal PET data on the rat brain.
Extension to automated whole-brain analysis methods, either by predefined VOI analysis or by statistical parametric mapping (SPM), has not been systematically investigated. Especially in SPM, voxel-based analysis may offer a unique way of extracting information in a fully automated data-driven approach, which has been shown to be superior in detecting pathologic signals in humans (10).
In the current study, we have used an existing 3-dimensional T2-weighted MRI template, aligned in space with the rat brain atlas of Paxinos (6), onto which we have mapped functional metabolic (18F-FDG), dopamine transporter (DAT) (using 2'-18F-fluoroethyl(1R-2-exo-3-exe)-8-methyl-3-(4-chlorophenyl)-8-azabicyclo[3.2.1]-octane-2-carboxylate [18F-FECT]), and dopaminergic D2 receptor (11C-raclopride) small-animal PET data of healthy rat brains to create ligand-specific templates for the assessment of metabolism and dopaminergic neurotransmission and to investigate population variability in radioligand distribution. First, the accuracy of the template registration process was assessed quantitatively for data on normal and lesioned animals. Second, testretest and intersubject variability and right-to-left asymmetry indices were determined for all used radioligands by applying the predefined VOI analysis. Finally, the feasibility of SPM in detailed regional analysis of molecular changes in the rat brain was explored in a model of Parkinson's disease, the 6-hydroxydopamine (6OHDA)lesioned rat model (11), by studying individual rat brains in comparison to a control group with both DAT and metabolic imaging.
| MATERIALS AND METHODS |
|---|
|
|
|---|
All animals were housed 3 to a cage, at an average room temperature of 22.4°C and with illumination available from 8 AM to 8 PM daily. Food and water were given ad libitum. The research protocols were approved by the local Animal Ethics Committee.
Tracer Synthesis
Functional images of the striatal dopamine system were obtained for each rat using the DAT radioligand 18F-FECT (n = 9, 1 animal died) (12) and the D2 receptor radioligand 11C-raclopride (n = 10) (13). Metabolic images were obtained using 18F-FDG (n = 10).
The 18F-FECT PET radiotracer was synthesized according to the procedure of Wilson et al. but using 2-18F-fluoroethyltrifluoromethanesulfonate instead of 2-18F-fluoroethylbromide (12). 11C-Raclopride was obtained by methylating the corresponding nor-precursor with 11C-methyltriflate, whereas 18F-FDG was prepared by using an Ion Beam Applications 18F-FDG synthesis module. Approximately 18 MBq (500 µCi) of each radioligand (specific activity range, 53760 GBq/µmol; injection volume, 500 µL) were injected into the tail vein using an infusion needle set.
Data Acquisition
Small-animal PET imaging was performed using a lutetium oxyorthosilicate detectorbased tomograph (microPET Focus 220; Siemens Medical Solutions USA, Inc.), which has a transaxial resolution of 1.35 mm in full width at half maximum. Data were acquired in a 128 x 128 x 95 matrix with a pixel width of 0.475 mm and a slice thickness of 0.796 mm. The coincidence window width was set at 6 ns. Before being imaged, the rats were anesthetized with an intraperitoneal injection of 50 mg of sodium pentobarbital (Nembutal; Ceva Sante Animale) per kilogram of body weight. All rats were breathing spontaneously throughout the entire experiment.
Timeactivity curves for the 3 tracers are shown in Figure 1. For 18F-FECT, pseudoequilibrium binding was reached approximately 3 h after injection. For atlas creation, static 18F-FECT measurements were obtained during 40 min starting 3 h after injection. For 18F-FDG, static acquisitions were performed for 40 min, starting 30 min after injection after overnight fasting (14). Although the timeactivity curve for 18F-FDG steadily increases up to 60 min after injection (Fig. 1), we applied an earlier, accurately timed starting point as used in previous literature (15). For 11C-raclopride, dynamic data were acquired during 60 min (frame duration: 4 x 15 s, 4 x 60 s, 5 x 180 s, and 8 x 300 s).
|
For every tracer, several control animals were scanned twice to estimate testretest variability (18F-FECT, n = 3; 11C-raclopride, n = 4; 18F-FDG, n = 6). The interval between the 2 scans was 1 d for 18F-FECT and, on average, 6 and 10 wk for 18F-FDG and 11C-raclopride, respectively.
Data Reconstruction
Small-animal PET studies were reconstructed using both filtered backprojection and a statistical maximum a posteriori probability algorithm (MAP) (18 iterations, ß = 0.5 resolution) (16). Compared with filtered backprojection, MAP has been shown to result in improved spatial resolution and noise properties on small-animal PET images (17)an advantage for image registration. On the other hand, filtered backprojection may more accurately estimate radioactivity concentration and was used for quantification. For 11C-raclopride data, MAP reconstructions were made of only the last 30 min of acquisition time. Randoms correction was performed using a delayed coincidence window; no corrections were made for attenuation or scatter.
Atlas Construction
The flowchart of the procedure for atlas creation is shown schematically in Figure 2. Construction of the 3-dimensional T2-weighted MRI template, which is aligned in space with the atlas of Paxinos, has previously been described extensively (6). The following within-modality procedure was repeated for all individual 18F-FECT, 11C-raclopride, and 18F-FDG MAP images of healthy subjects. Of the individual PET images, one was selected as the "representative" brain. Each individual PET scan was then transformed into the space of the representative scan. Data voxel size was scaled by a factor of 10 to approximately fit the human brain size so that default parameter settings in SPM could be applied. This within-modality registration of individual data was performed using the sum-of-squared-differences minimization algorithm and 12-parameter affine transformations only in SPM2 (Wellcome Department of Cognitive Neurology), because this provided the best results on a visual basis. The normalized image datasets were averaged voxelwise to create functional image atlases using the SPM Imcalc function.
|
Making use of the stereotactic rat brain atlas of Paxinos, we defined on the MRI template a VOI map representing the major cortical and subcortical structures of the rat brain (5). Each region was primarily defined on horizontal slices, with sagittal and coronal slices used to confirm regional boundaries (PMOD, version 2.65; PMOD Inc.). VOIs were defined separately for the left and right hemispheres and covered 51 slices of the MRI template. VOIs were defined for the rat brain caudate-putamen, globus pallidus, nucleus accumbens, cerebellum, cerebral cortex, thalamus, hypothalamus, hippocampus, pituitary gland, and pons (substantia nigra). The VOIs, superimposed on horizontal slices of the rat brain MRI atlas, are displayed in Figure 3.
|
|
Determination of Registration Accuracy
The following experiment was performed to quantitatively assess the registration accuracy of mapping individual MAP data to the ligand-specific PET templates. The anatomically standardized image volume from a MAP PET study of a control animal and a 6OHDA-lesioned animal underwent 40 random misalignments each time: 10 translations, 10 rotations, 10 linear stretchings, and 10 combinations of the 3 previous parameters. This was done for all 3 tracers in the case of the control animal and for the 18F-FECT and 18F-FDG data in the case of the 6OHDA-lesioned rat. The misalignments were uniformly distributed (random number generation function in Excel 2003; Microsoft) within 5 to +5 mm of translation, 20° to +20° of rotation, and 10% to +10% of scaling along the 3 orthogonal axes/planes. For the combination misalignments, rotations were allowed only within a range of 10° in the 3 main planes. The amount of deliberate misalignment was based on typical magnitudes that can occur in realistic situations. Each resultant image volume was then reregistered to the study-specific template using the automated spatial normalization procedure (12-parameter affine) integrated in SPM2. For each voxel (x,y,z) in the original image, the position (x +
x, y +
y, z +
z) after reregistration was computed. This position was determined by means of 3 self-constructed images in which neighboring voxels differed by 1 unit in the x, y, and z directions. The distance (
was averaged over all rat brain voxels and used as a measure of accuracy.
General Statistics
Regional intersubject and testretest variability, as well as right-to-left asymmetry indices, were calculated from VOI-derived measurements of radioactivity concentration. The testretest variability for radioligand index (relative metabolic activity and binding index) Ri in VOI region i was determined as |Ri,1 Ri,2| x 2/(Ri,1 + Ri,2), where the indices 1 and 2 refer to the 2 different scans of the same animal.
SPM
A categoric subject design using conditions (disease vs. controls) was performed on parametric DAT and 18F-FDG images of 3 individual 6OHDA-lesioned rats in comparison to the respective control data. Spatially normalized images were masked to remove extracerebral signal that would disrupt the global normalization for 18F-FDG. All images were smoothed with a 16-mm isotropic gaussian kernel. SPM analysis of parametric DAT data was performed without global normalization, whereas for 18F-FDG data, proportional scaling with a threshold of 0.8 of the maximum image intensity was applied (scaled to 50 mL/100 g/min). For statistical analysis, T-map data were interrogated at a peak probability level of 0.001 (uncorrected) and an extent threshold of more than 50 voxels, unless indicated otherwise. Because of the conventional orientation in SPM2, the x-axis in the MRI template is negative to the right of the midline and positive to the left (6).
| RESULTS |
|---|
|
|
|---|
|
As for 11C-raclopride, caudate-putamen binding is on average 2.45, with an SD of 0.27, which is comparable to the situation in humans, where a factor of 2.35 is found in healthy subjects (20). Modest uptake is also seen in the brain stem, including the inferior colliculus. The testretest variability of the caudate-putamen was on the same order as intersubject variability for 11C-raclopride, namely 14.0% and 11.0%, respectively.
18F-FECT shows a high binding index of almost 9 and a relatively low intersubject variation of 5.3%. Testretest variability was 7.7% for the caudate-putamen and 10.4% for the nucleus accumbens. The values of testretest variability for 18F-FECT and 11C-raclopride were determined in a small sample, which is likely to give conservative values.
Registration Accuracy
Table 2 summarizes mean registration errors obtained when comparing guided misaligned MAP PET image volumes from a control and a 6OHDA-lesioned animal with their original spatially normalized image volumes. All results are reported in real distances (scaling factor of the images in SPM taken into consideration, so the reconstructed pixel size is actually 0.2 mm).
|
Reregistration of randomly misaligned data to the ligand-specific templates was less accurate for 6OHDA-lesioned rat data in comparison to control data, because of the induced lesion and the corresponding functional alterations, which result in asymmetric image information. The largest registration error was obtained for 18F-FECT data. The average combined error was 0.862 mm (range, 0.0032.601 mm), whereas the average linear stretching error was 0.812 mm (range, 0.0044.244 mm). The average 18F-FECT translation and rotation errors were 0.734 mm (range, 0.0111.514 mm) and 0.712 mm (range, 0.0011.920 mm), respectively. Reregistration of one 18F-FECT MAP image volume with the highest rotation values failed, and this outlier result was excluded. For 18F-FDG, the average translation and rotation errors were both 0.580 mm (translation range, 0.0891.545 mm; rotation range, 0.0891.544 mm), whereas the average combination and linear stretching errors were 0.577 mm (range, 0.0871.573 mm) and 0.585 mm (range, 0.0841.630 mm), respectively.
SPM Analysis of 6OHDA-Lesioned Rat Model
Statistical parametric maps from the metabolic/presynaptic dopaminergic characterization of individual 6OHDA-lesioned rats, compared with the control group, are shown in Figure 5. A highly significant reduction in DAT availability in the right striatum is seen in the lesioned rats, compared with the controls (P
0.0005, corrected for multiple comparisons; Paxinos coordinate peak maximum, (x,y,z) = (3.8, 0.8, 5.8) for all subjects). The intensity of the deficit (percentage change in right striatal binding index vs. controls) was 99.4%, 98.0%, and 95.4% for the 3 animals.
|
0.0004; peak maximum, (3.6, 0.8, 2.0), (3.4, 0.4, 2.0), (3.4, 0.8, 2.0) for subjects A, B, and C, respectively). The mean glucose metabolic decrease was 10.0% versus controls (12.1%, 8.3%, and 8.8% for subjects A, B, and C, respectively). | DISCUSSION |
|---|
|
|
|---|
The total number of resolution elements in the rat brain (weighing about 12 g (21)) is limited to a few hundred calculated from a resolution of 1.5 mm in full width at half maximum. It is therefore of the utmost importance that the amount of information be used maximally in these functional images. The limitations of operator-dependent ROI or VOI approaches are well known (10). The optimal way to maximize performance is by using a data-driven approach such as SPM, whereas in some instancesfor reasons of a priori hypotheses or for sensitivity reasonsa predefined-VOI approach may be preferred (22). In both cases, added variability through inter- and intraobserver subjectivity in placement of regions is eliminated.
In our approach, use of an average small-animal MRI template, aligned in space with the rat brain Paxinos atlas, allows the reporting of SPM results in coordinates directly corresponding to the Paxinos coordinate system, as well as an accurate definition of all major VOI structures because of the direct relationship between the coordinates of the Paxinos atlas and the MRI template voxels (6).
The constructed probabilistic PET atlases were averaged from several female Wistar rats. However, because of the similar anatomy for the given weight range, the atlases may also be used for spatial normalization of similar strains of rats or for the male sex (23), although the uptake values or binding indices might theoretically differ slightly because of changes in the menstrual cycle or other hormonal effects. These effects are second order for the current tracers when studied in humans and need to be investigated in more detail in rodents.
Validation of registration accuracy is of vital importance but often difficult. Determining registration errors by observer assessment and external fiducial markers has some drawbacks. As was our experience, reproducibility of animal positioning within a restraining or even stereotactic device proves to be insufficient for calibration purposes. The applied technique of reregistration of controlled misregistrations to evaluate the performance of a registration algorithm has been used in several studies (9,24). This technique assesses the robustness of the registration algorithm, thereby giving a realistic idea of the accuracy that can be obtained.
The automated spatial normalization procedure (12-parameter affine) integrated in SPM2 succeeded in obtaining similar registration accuracies independent of the type of transformation applied a priori. Registration errors within the range of 0.240.86 mm indicate that a sufficient accuracy for novel animals can be achieved for subsequent quantitative analysis. The registration errors found in this study, both for normal and pathologic data, are in relative agreement with published human data when relative values are considered with respect to imaging resolution (e.g., corresponding to 2- to 3-mm accuracy for PET or SPECT devices with 4- to 10-mm resolution) (25). They are, however, higher than the values reported by Rubins et al., who found an accuracy of 0.05 mm and 0.05° using the mutual-information algorithm to reregister misaligned PET images of the rat brain (9), but the accuracy was not clearly defined in their work and they applied translation and rotation separately on a single image. Moreover, the registration errors found in this work are even better than the errors obtained when using a stereotactic frame for repositioning the rat brain in serial PET studies (15).
Few reports have studied the implications of misalignments on quantitative measures in the (human) brain. Sychra et al. found that registration errors for single-axis-shift differences of 0.7 mm and 1° of rotation may produce intensity errors of 5%10% on the voxel level using a voxel size of 5.6 mm (26). However, this estimation produces a maximum possible error that is diminished by considering larger adjacent regions or clusters as is done with the SPM approach, where smoothing is the standard applied technique to level out intersubject anatomic differences in the spatial normalization method. Therefore, it is expected that VOI analysis and statistical voxel-based analysis will result in significantly lower (semi)quantitative errors.
The mean translation, rotation, linear stretching, and combination errors found for the control animal in this work were strongly dependent on the radioligand used. The striatal specific uptake and the global cerebral aspecific distribution of raclopride, with the exception of some midbrain areas, proved to be superior in registration accuracy. On the opposite side, 18F-FECT uptake is characterized by a high signal-to-noise ratio and poor anatomic information because of the high specificity of the ligand used. Lesion induction and corresponding functional alterations resulted in less accurate registrations for the radioligands used, but still below the system resolution and comparable to pathologic human data.
The reported intersubject variability comprises image registration error, true nonlinear anatomic differences among the individual rat brains, and functional differences. In humans, variations in anatomy are often reduced by applying nonlinear warping techniques during spatial normalization, whereas in this study only affine transformations were applied. In this work, we have not yet considered applying nonlinear deformations because these need to be validated in detail for the rat brain, especially lesioned brains (27). Testretest coefficients of variation, shown in Table 1, are consistent in magnitude with published measurements in humans (2830) and in animal pilot studies using 123I-N-
-fluoropropyl-2-ß-carboxymethoxy-3ß-(4-iodophenyl)nortropane small-animal SPECT (31) and 11C-raclopride small-animal PET (32). This finding confirms the possible utility of small-animal imaging as a precise molecular biomarker tool for longitudinal evaluation, such as in studies of disease progression or after neuromodulatory interventions. In view of the known negative aging effect of dopamine D2 receptor expression (33) and the possibility of additional environmental influences, the relatively long interval between 11C-raclopride PET scans (average, 10 wk) can be seen as a conservative estimate for the reproducibility of 11C-raclopride imaging in rats.
Examination of the intersubject and testretest variability of template VOI measurements only within our method may not provide insight into the accuracy of the template method itself, because variability reflects several factors other than the accuracy of registration. Previous studies have compared intersubject and testretest variability values between template-based methods and the traditional individual VOI method without using templates. In control animals, Rubins et al. (9) found a significant decrease in rightleft binding index differences using their cryosectioned atlas-derived VOI method than using manually drawn ROIs. The testretest variability was also lower using an atlas-derived VOI method. Moreover, reduced intersubject and testretest variability by atlas-derived methods has been demonstrated repeatedly for human brain imaging.
Additionally, we demonstrated the feasibility of using the functional rat brain templates in an experiment to characterize metabolic/dopaminergic alterations in a 6OHDA rat model of acute Parkinson's disease. The reduction in striatal DAT binding is a well-known feature in 6OHDA-lesioned rats, primarily validated using invasive histologic and electrophysiologic analysis (34), and correlates to the nigrostriatal dopaminergic damage inflicted by toxin administration (35). Additionally, a metabolic decrease in the ipsilateral sensorimotor cortex was found, pointing to a hypofunctional striatocortical network that corresponds to corticosubcortical network findings in humans (36). This feasibility substudy therefore shows that multitracer small-animal PET is a promising and sensitive tool for evaluations of rat models of brain disease and translational investigations of correspondence to human disease.
An important limitation of the study, and an issue for further research, is correction for the partial-volume effect (37). At present, even the relatively high resolution of the microPET Focus 220 precludes detailed functional brain scanning in mice for most applications. Nevertheless, the availability of multiple transgenic mouse models for various neurologic disorders would allow the neuroimaging community to take a giant leap into functional characterization of these widely studied and well-characterized genetically induced disease models. Also, for identification of activity in smaller nuclei centrally in the rat brain, partial-volume-effect corrections would be advantageous. For such applications, first, the issues of (automated) intermodality high-resolution small-animal PET-to-MRI registration need to be resolved, and segmentation algorithms need to be optimized for rodent brains. Then, algorithms for partial-volume-effect correction that have been developed for human brain imaging (38,39) could be extended to use in rodents.
In comparison to human studies, the animals in this study received a relatively high dose of radiotracer. Because the average weight of humans versus rats has a ratio of approximately 300, care needs to be taken not to induce pharmacologic effects. For the specific activity administered, the calculated percentage receptor occupancy of 11C-raclopride ranged from 0.4% to 8%. This range is still unlikely to induce a major pharmacologic effect, such as dyskinesia, which is observed at an occupancy of over 50% for dopamine D2 receptors (40).
| CONCLUSION |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
| References |
|---|
|
|
|---|
Related articles in JNM:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |